These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation. Kiec-Klimczak M, Malczewska-Malec M, Razny U, Zdzienicka A, Gruca A, Goralska J, Pach D, Gilis-Januszewska A, Dembinska-Kiec A, Hubalewska-Dydejczyk A. J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181 [Abstract] [Full Text] [Related]
4. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus. Cypryk K, Vilsbøll T, Nadel I, Smyczyńska J, Holst JJ, Lewiński A. Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514 [Abstract] [Full Text] [Related]
18. Incretin and islet hormone responses to meals of increasing size in healthy subjects. Alsalim W, Omar B, Pacini G, Bizzotto R, Mari A, Ahrén B. J Clin Endocrinol Metab; 2015 Feb; 100(2):561-8. PubMed ID: 25375983 [Abstract] [Full Text] [Related]
19. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M. Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587 [Abstract] [Full Text] [Related]